Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited - pharma in Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India. FY 2026 financials and compliance.
CIN U00304HP2005PLC029451 Incorporated 30 December 2005 ROC Himachal Pradesh HQ Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹209.4 Cr
▲ 46.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹25.45 Cr
Registered with MCA
Paid-up capital
₹25.34 Cr
Issued & subscribed
Open charges
₹212.08 Cr
Satisfied ₹122.92 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
343
Latest available

About Biodeal Pharmaceuticals Limited

Data last updated: 05 January 2026

Biodeal Pharmaceuticals Limited is a public limited company based in Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 30 December 2005, the company has been in operation for over 21 years.

Registered with ROC Himachal Pradesh under CIN U00304HP2005PLC029451.

Capital: an authorised share capital of ₹25.45 Cr and a paid-up capital of ₹25.34 Cr. It is led by directors including Dev Datt and Anurag Kumar.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Village Saini Majra Nalagarh – Ropar Road Teh. Nalagarh Distt. Solan (Hp)., Himachal Pradesh, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹209.4 Cr, a growth of 46% compared to the previous year.

The company has a workforce of approximately 343 employees as per the latest available data.

The company is associated with 1 brand - Biodeal Pharmaceuticals. As per MCA filings, the company has open charges of ₹212.08 Cr and satisfied charges of ₹122.92 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biodealpharma.com.

Company Details of Biodeal Pharmaceuticals Limited
CIN U00304HP2005PLC029451
Registration Number 029451
Incorporation Date 30 December 2005
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Village Saini Majra Nalagarh – Ropar Road Teh. Nalagarh Distt. Solan (Hp)., Himachal Pradesh, India
  • Industry
    Pharma, Drug Formulation & Development
Company report
Biodeal Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Biodeal Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Biodeal Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U00304HP2005PTC029451. The current CIN is U00304HP2005PLC029451, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U00304HP2005PLC029451 Current
U00304HP2005PTC029451 Previous

Associated Brands with Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited operates one associated brand: Biodeal Pharmaceuticals. These brands represent Biodeal Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Pharmaceutical formulations are manufactured by Biodeal Pharmaceuticals in Delhi. biodealpharma.com

Competitors & Alternatives of Biodeal Pharmaceuticals Limited

Brands and companies operating in the same space as Biodeal Pharmaceuticals Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Biodeal Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited is audited by Khandelwal Jain & Co (Chartered Accountants) for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Khandelwal Jain & Co (Chartered Accountants) Locked Locked Locked
Premium access

Complete auditor history for Biodeal Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited is currently managed by 6 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Dev Datt Director 01 Apr 2021 5 Years 3 Months Current
Anurag Kumar Managing Director 31 Dec 2020 5 Years 6 Months Current
Anchal Kumari Director 30 Nov 2022 3 Years 7 Months Current
Noopur Jha Director 14 Jun 2024 2 Years 1 Months Current
Abhishek Jain Nominee Director 16 May 2025 1 Years 2 Months Current
Adheesh Chander Malhotra Additional Director 20 Jun 2025 1 Years 0 Months Current

Financials of Biodeal Pharmaceuticals Limited FY 2025 filings available

Biodeal Pharmaceuticals Limited reported revenue of ₹209.4 Cr (up 46.00% YoY) for FY 2025.

Revenue · FY 2025
₹209.4 Cr ▲ 46.00%
Premium access

Ten-year financial statements for Biodeal Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Biodeal Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Biodeal Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Biodeal Pharmaceuticals Limited

Open charges
₹212.08 Cr
Satisfied charges
₹122.92 Cr
Breakdown by lending institutions
Others₹110.00 Cr
Yes Bank Limited₹50.00 Cr
Axis Bank Limited₹50.00 Cr
Hdfc Bank Limited₹2.08 Cr
Latest charge details
DateLenderAmountStatus
18 Oct 2025 Axis Bank Limited ₹50 Cr Open
25 Sep 2025 Hdfc Bank Limited ₹1.31 Cr Open
29 Aug 2025 Hdfc Bank Limited ₹31.4 Lakh Open
06 May 2025 Hdfc Bank Limited ₹11.42 Lakh Open
21 Feb 2025 Hdfc Bank Limited ₹24.63 Lakh Open

Total charge records: 28 View all charges

Employees and EPFO Compliance at Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited has a workforce of 343 employees as of Apr 10, 2025.

Employee count
343
Active EPFO establishments
1
Employee growth
20.77%
Premium access

Employee and EPFO history for Biodeal Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Biodeal Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Biodeal Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Biodeal Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Biodeal Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Biodeal Pharmaceuticals Limited

Premium access

MSME payment history for Biodeal Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Biodeal Pharmaceuticals Limited

Premium access

Corporate group structure for Biodeal Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Biodeal Pharmaceuticals Limited

Premium access

MCA filings and documents for Biodeal Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Biodeal Pharmaceuticals Limited

Charges
20 Nov 2025
A charge registered on 18 Jan 2022 via Charge ID 100527051 with Sidbi was fully satisfied on 20 Nov 2025.
Directors
07 Nov 2025
Sanjay Kumar Sharma was appointed as a Ceo on 07 Nov 2025 & has been associated with this company since 8 months 7 days.
Charges
18 Oct 2025
A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101182326 was registered on 18 Oct 2025.
Directors
04 Oct 2025
Rishi Kapoor was appointed as a Cfo on 04 Oct 2025 & has been associated with this company since 9 months 11 days.
Activity
30 Sep 2025
Biodeal Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
25 Sep 2025
A charge with Hdfc Bank Limited amounted to Rs. 1.31 Cr with Charge ID 101188927 was registered on 25 Sep 2025.

Frequently Asked Questions about Biodeal Pharmaceuticals Limited

Biodeal Pharmaceuticals Limited is an active public limited company in the pharma sector based in Nalagarh, Distt. Solan (Hp), Himachal Pradesh, India. It was incorporated on 30 December 2005 (21+ years old) and is registered under CIN U00304HP2005PLC029451. The company has 343 employees.

Biodeal Pharmaceuticals Limited reported revenue of ₹209.4 Cr for FY 2025 (up 46.00% YoY).

The current directors of Biodeal Pharmaceuticals Limited are:

The primary industry of Biodeal Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Biodeal Pharmaceuticals Limited can be reached at the registered office: Village Saini Majra Nalagarh – Ropar Road Teh. Nalagarh Distt. Solan Hp, Himachal Pradesh, India, or through the website biodealpharma.com.

The authorised capital is ₹25.45 Cr, and the paid-up capital is ₹25.34 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available